CVS Health Corp Congressional Trading
According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 360 trades in CVS Health Corp (NYSE: CVS) since 2014, across 73 members, worth an estimated $8.8M in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). 172 buys against 187 sells, a modestly sell-led skew, with Democratic members responsible for 44% of the trades and Republican members 56%. The most recent disclosure shown was filed July 2026, and Rohit Khanna has filed the most CVS transactions among those shown, with 6. Other recent filers include Alan Armstrong, Michael T. McCaul, and John Boozman. One notable disclosed move was a purchase by Alan Armstrong on March 27, 2026, up 33.7% since. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the CVS Health Corp (CVS) stock overview and the complete trade table below.
Data updated
Price & congressional trade timeline
Party breakdown
CVS Health congressional trading activity
| Politician | Published | Traded | Filed After | Type | Size | Return | Owner | |
|---|---|---|---|---|---|---|---|---|
 Rohit Khanna House | Jul 6, 2026 | Jun 2, 2026 | 34 days | BUY |  $1,001 - $15,000 | +3.80% | Child | |
Rohit Khanna House | Jun 9, 2026 | May 15, 2026 | 25 days | BUY | $1,001 - $15,000 | -3.12% | Spouse | |
Rohit Khanna House | Jun 9, 2026 | May 1, 2026 | 39 days | BUY | $1,001 - $15,000 | +13.17% | Child | |
Rohit Khanna House | May 11, 2026 | Apr 13, 2026 | 28 days | BUY | $1,001 - $15,000 | +20.01% | Spouse | |
 Alan Armstrong Senate | Jul 21, 2026 | Mar 27, 2026 | 116 days | BUY | $1,001 - $15,000 | +33.73% | Self | |
Rohit Khanna House | Mar 9, 2026 | Feb 24, 2026 | 13 days | SELL | $1,001 - $15,000 | +26.34% | Child | |
 Michael T. McCaul House | Mar 10, 2026 | Feb 20, 2026 | 18 days | BUY | $15,001 - $50,000 | +22.20% | Spouse | |
 John Boozman Senate | Feb 15, 2026 | Jan 29, 2026 | 17 days | BUY | $1,001 - $15,000 | +25.89% | Joint | |
Rohit Khanna House | Feb 6, 2026 | Jan 29, 2026 | 8 days | BUY | $1,001 - $15,000 | +25.89% | Spouse | |
Michael T. McCaul House | Feb 11, 2026 | Jan 13, 2026 | 29 days | SELL | $15,001 - $50,000 | +17.11% | Spouse |
CVS Health (CVS) congressional trading FAQ
Can members of Congress legally trade CVS Health (CVS) stock?
Yes. Members of Congress are permitted to trade individual stocks, including CVS Health (CVS), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; it does not imply any trade was improper.
Are congressional CVS Health (CVS) trades public?
Yes. Every congressional trade in CVS Health (CVS) on this page comes from mandatory public STOCK Act disclosure filings, which are filed with a delay and may be revised.
How many times has Congress traded CVS Health (CVS)?
Members of Congress have disclosed 360 trades in CVS Health (CVS) worth $8.8M across 73 members, according to public STOCK Act filings.
Which members of Congress have traded CVS Health (CVS)?
Recent and active filers of CVS Health (CVS) disclosures include Rohit Khanna, Michael T. McCaul, Lisa McClain. The full member-by-member trade list is on this page.
Do Democrats or Republicans trade CVS Health (CVS) more?
Across disclosed CVS Health (CVS) trades, 44% were by Democrats and 56% by Republicans, led by Republicans (56%).
What is the most recent congressional CVS Health (CVS) trade?
The most recent disclosed CVS Health (CVS) trade was a purchase by Alan Armstrong, filed Jul 20, 2026.
Browse all stocks Congress tradesCongressional trading overviewCVS Health (CVS) stock overview
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. The Tide Score and other figures are generated algorithmically from public filings and market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.